| For: | Zhou XQ, Li YP, Dang SS. Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy. World J Hepatol 2024; 16(2): 164-176 [PMID: 38495282 DOI: 10.4254/wjh.v16.i2.164] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i2/164.htm |
| Number | Citing Articles |
| 1 |
Jinbang Huang, Shi Huang, Wenjing Chen, Shunsheng Wang, Zhihao Zuo, Xinyan Wu, Gang Deng. Nanomaterial-based strategies to overcome sorafenib resistance in hepatocellular carcinoma: from mechanistic insights to translational applications. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1839966
|
| 2 |
Marwa Alawi, Mohammad Raahim, Mohit Kumar, Kim Ling Chin, Pornanong Aramwit, Syed Mahmood. Therapeutic Potential of Silver Nanoparticles in Hepatocellular Carcinoma: From Pathogenesis to Clinical Perspectives. International Journal of Nanomedicine 2026; doi: 10.2147/IJN.S573137
|
| 3 |
Zhilan Zhang, Longbao Feng, Heng Zhang, Yuanhui Gao, Dingmao Wang, Jianquan Zhang, Yang Xiang. Tumor cell membrane-coated acid-responsive CaCO3/MnCO nanoplatform for Ca2+ overload-amplified immunogenic cell death and STING-mediated cancer immunotherapy. Chemical Engineering Journal 2026; 545 doi: 10.1016/j.cej.2026.179661
|
| 4 |
Siyao Wang, Yang Wu, Miao Yuan, Jing Zheng, Chaoran Wang, Jiarong Wang, Yifan Zheng, Qiaoyun Yang, Mengran Xu, Baiqi Wang. Nanotechnology-Enabled Diagnosis and Treatment of Hepatocellular Carcinoma: Theranostics, Combination Regimens, and Translation. International Journal of Nanomedicine 2026; doi: 10.2147/IJN.S581911
|
| 5 |
Balaji Palanisamy, Abul Kalam Azad Mandal. Unlocking the potential: Receptor-mediated targeted drug delivery in cancer therapy. Pathology - Research and Practice 2025; 270 doi: 10.1016/j.prp.2025.155955
|
| 6 |
Ayhan Bergal, Muberra Andac, Francesco Trotta. Cyclodextrin-based chemically modified pH-Responsive new kind of aldehyde-functionalized nanosponge nanoparticles for doxorubicin hydrochloride delivery. Journal of Drug Delivery Science and Technology 2025; 107 doi: 10.1016/j.jddst.2025.106853
|
| 7 |
Veena Vijayan, Janitha M. Unagolla, Dhruvisha Panchal, Judith Eloyi John, Siddharth S. Menon, Jyothi U. Menon. Biomimetic nanoparticles for targeted therapy of liver disease. RSC Pharmaceutics 2025; 2(4) doi: 10.1039/D5PM00044K
|
| 8 |
Devansh Shah, Aryan Thakkar, Sankha Bhattacharya. Hyaluronic Acid-Polyethylene Glycol-Polycaprolactone Nanocarriers: Accurate Targeting and Multimodal Treatment for Aggressive Cancers. Journal of Macromolecular Science, Part B 2026; 65(9) doi: 10.1080/00222348.2025.2537449
|
| 9 |
Yeongbeom Kim, Jaewoo Kwak, Minyeong Lim, Su Yeon Lim, Sehyun Chae, Suk-Jin Ha, Young-Wook Won, Hyun-Ouk Kim, Kwang Suk Lim. Advances in PCL, PLA, and PLGA-Based Technologies for Anticancer Drug Delivery. Pharmaceutics 2025; 17(10) doi: 10.3390/pharmaceutics17101354
|
| 10 |
Sina Nabiyi, Mohammad Heiat, Ehsan Rezaei. Combination therapy strategies targeting glypican-3 in hepatocellular carcinoma: A comprehensive review. Cytokine & Growth Factor Reviews 2026; 87 doi: 10.1016/j.cytogfr.2025.12.006
|
| 11 |
Remya Radha, Shabana Anjum, Rand Hasan Abusamra, Vinod Paul, William G. Pitt, Ghaleb A. Husseini, Mohammad H. Al-Sayah, Lei Zhang. Ultrasound-triggered doxorubicin targeted delivery for liver cancer treatment: Reduced toxicity and improved efficacy. PLOS One 2026; 21(3) doi: 10.1371/journal.pone.0345161
|
| 12 |
Hanlin Gao, Zhuoyan Lei, Luye Wang, Yumo Li, Zhi Chen, Gang Wang. The role of HBV in reprogramming liver cancer stem cells and shaping their plasticity and therapeutic vulnerabilities. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-05436-9
|
| 13 |
Howard D Lee, Li-Yun Yuan. Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet?. World Journal of Hepatology 2024; 16(5): 684-687 doi: 10.4254/wjh.v16.i5.684
|
| 14 |
Amria M. Mousa, Mohamed Abdelraof, Amany A. Hassabo, Doaa A. Darwish, Mona M.A. Abdel-Mottaleb, Rasha M. Allam. Marine L-arginase encapsulated in poly (lactic-co-glycolic acid) nanoparticles: A novel anti-cancer strategy for effective hepatocellular carcinoma treatment in vitro and in vivo. Journal of Drug Delivery Science and Technology 2025; 109 doi: 10.1016/j.jddst.2025.106980
|
| 15 |
Mohammad S. Alzahrani, Bandar Almutairy, Yusuf S. Althobaiti, Hashem O. Alsaab. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA. Cell Biochemistry and Biophysics 2024; 82(3) doi: 10.1007/s12013-024-01395-6
|
| 16 |
Sweta Tripathi, Siddhartha Kumar Mishra. Liver Cancer - Recent Advances in 2026. Oncology 2026; 18 doi: 10.5772/intechopen.1014017
|
| 17 |
Zhuanxia He, Limin Zhang, Jiaxin Zhong, Xiujun Gao, Yanqi Zhang, Feng Gao. Activatable Phototheranostic
Nanoplatform for Fluorescence
Turn-On Imaging and Photodynamic Immunotherapy of Liver Cancer. ACS Applied Polymer Materials 2026; 8(18) doi: 10.1021/acsapm.6c02877
|
| 18 |
Houemakou Rimaud Djidonou, Laís de Carvalho Gonçalves, Djorkaeff O. Fontinele, Daner A. Silveira, Marialva Sinigaglia, Joao Paulo M. S. Lima, José Carlos M. Mombach, Shantanu Gupta. MYC–SNHG7–miR-34a-5p Feedback Loop Orchestrates GSDMD-Dependent Pyroptosis in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2026; 27(19) doi: 10.3390/ijms27198441
|
| 19 |
Athirah Iskandar, Yazid Zaiki, Tin Wui Wong. Pectin as cancer targeting nano-vehicle and therapeutic — Physicochemical-biological perspectives: A review. Biomaterials Advances 2026; 180 doi: 10.1016/j.bioadv.2025.214562
|